Enovis Corporation
Long

ENOV SVP & CLO Tandy Bradley J bought 3,200 shares at $31.41

78
ENOV #ENOV - Enovis Corp | Healthcare | Medical Devices | USA | NYSE

The recent insider transaction reveals that Tandy Bradley J, SVP and Chief Legal Officer of Enovis Corporation (ENOV), executed a purchase of 3,200 shares on August 22, 2025, at a cost of $31.41 per share, totaling a value of $100,512.

This move, reported via SEC Form 4 on August 25, 2025, at 06:30 AM EDT, signals strong confidence from a key executive.

SEC From 4:
sec.gov/Archives/edgar/data/1358283/000135828325000004/xslF345X05/ownership.xml

Chart:

• (1D)
snapshot

• (1W)
snapshot

Analyzing the weekly chart for ENOV, the purchase appears well-timed. The stock has experienced a significant correction, dropping from its highs, which aligns with a potential accumulation phase.

The current price level near $30.88 offers a compelling entry point, supported by historical support zones.

Given the insider's conviction and the stock's technical setup, a recovery targeting 20-40% upside to the $37-$43 range seems plausible in the coming months, assuming market conditions remain favorable.

Wyłączenie odpowiedzialności

Informacje i publikacje nie stanowią i nie powinny być traktowane jako porady finansowe, inwestycyjne, tradingowe ani jakiekolwiek inne rekomendacje dostarczane lub zatwierdzone przez TradingView. Więcej informacji znajduje się w Warunkach użytkowania.